M. Ali

5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney).

I. Kaplan, R. Hannan, H. Onishi, 2022, The Lancet. Oncology.